Q2 2026 CV Sciences Inc Earnings Call Transcript
Key Points
- Gross margin remained strong at 48.6%, demonstrating effective cost control despite rising expenses.
- Operating expenses were reduced by 7.9% sequentially, reflecting ongoing cost discipline and structural efficiencies.
- Generated positive operating cash flow of approximately $20,000 for the second consecutive quarter, a key milestone.
- Launched plushealth.com, a new direct-to-consumer platform for non-cannabinoid products, supporting diversification strategy.
- Introduced new Empower product with 20g protein and creatine, expanding the PlusHealth portfolio to address broader health and wellness trends.
- Revenue declined 7% sequentially and 17% year-over-year, driven by a 15% drop in unit sales.
- Gross margin decreased year-over-year from 50.9% to 48.6%, due to higher freight costs and product/channel mix.
- Net loss widened to $0.8 million in Q2 2026 from $0.3 million in the prior year period.
- Cash balance remains low at approximately $0.3 million, limiting financial flexibility.
- Regulatory uncertainty persists, with potential changes from the November 2025 Appropriations Act that could force product modifications.
Greetings. Welcome to the CV Sciences Incorporated Q2 2026 earnings call. (Operator Instructions) Please note this conference is being recorded.
I will now turn the conference over to Brendan Hawkins. You may begin.
Thank you, and good afternoon, everyone. With us today with prepared remarks are CV Sciences' Chief Executive Officer, Joseph Dowling; and Joerg Grasser, Chief Financial Officer. After the prepared remarks, we will take questions from the analyst community. I'd like to remind you that during this call, management's prepared remarks may contain forward-looking statements. These forward-looking statements are subject to risk and uncertainties that may cause actual results to differ materially from those anticipated by CV Sciences at this time.
When used in this call, the words anticipate, could, estimate, intend, expect, believe, potential, will, should, project, and similar expressions as they relate to CV Sciences are as such a forward-looking statement. Finally, please note
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
